FDA Adverse Event Injury Summary report: N

BOOMERANG CATALYST II SYSTEM

MDR report key: 1060270 · Received June 10, 2008

Report

Report Number
3004182619-2008-00012
Event Type
Injury
Date Received
June 10, 2008
Date of Event
May 8, 2008
Report Date
May 14, 2008
Manufacturer
CARDIVA MEDICAL, INC.
Product Code
DXC
PMA / PMN Number
K072297
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE BOOMERANG CATALYST II WAS DISCARDED AT THE HOSPITAL AND WAS NOT RETURNED TO THE MANUFACTURER FOR EVAL. IT WAS REPORTED THE PRODUCT DEPLOYED AND DE-DEPLOYED AS INTENDED. REVIEW OF THE BATCH RECORD WAS UNABLE TO BE PERFORMED, BECAUSE THE LOT NUMBER WAS NOT PROVIDED AND NO LONGER AVAILABLE. THE BCW PERFORMANCE WAS NOT CLINICALLY EVALUATED FOR GRAFTED ARTERIES.

Description of Event or Problem · 1

A PERIPHERAL INTERVENTIAL CASE WAS PERFORMED IN 2008, ON A FEMALE PT WITH PVD, HYPERTENSION, FEM-FEM BYPASS, GRAFTS IN BOTH FEMORAL ARTERIES, DIABETIC AND ARTERIOSTENOSIS. A 6 FR SHEATH WAS PLACED IN THE SYNTHETIC RIGHT FEMORAL COMMON ARTERY (RFCA) AND HEPARIN WAS ADMINISTERED. UPON COMPLETION OF THE PROCEDURE, A BOOMERANG CATALYST II WIRE (BCW) WAS INSERTED AND DEPLOYED THRU THE INDWELLING SHEATH W/O PROBLEM. TEMPORARY TAMPONADE OF THE ARTERIAL ACCESS WAS NOT ACHIEVED. THERE WAS CONSISTENT OOZING AROUND THE BCW. DWELL TIME WAS FOR 30 MINUTES TOTAL. PT BEGAN TO VOMIT. BCW WAS DEDEPLOYED AND REMOVED W/O INCIDENT. UPON REMOVAL, A HEMATOMA (>6 CM) STARTED TO FORM. FEMSTOP WAS APPLIED AND MANUAL COMPRESSION WAS APPLIED TO ACHIEVE FINAL HEMOSTASIS. TWO UNITS OF PACKED RED BLOOD CELL (PRBC) WAS ADMINISTERED. PT WAS ADMITTED FOR OBSERVATION. THE FOLLOWING DAY, PT WAS ADMINISTERED 1 UNIT OF PRBC. AT 3 DAYS POST OP, PT WAS DISCHARGED WITHOUT SEQUELAE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BOOMERANG CATALYST II SYSTEM VASCULAR CLAMP DXC CARDIVA MEDICAL, INC. 500-580C NA

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R 6 FR SHEATH